SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-16-029616
Filing Date
2016-09-13
Accepted
2016-09-13 17:24:09
Documents
1
Period of Report
2016-09-08

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - edgar.html 4/A  
1 FORM 4/A - edgar.xml 4/A 4390
  Complete submission text file 0001179110-16-029616.txt   5844
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ., BLDG. 1400E, STE.B14202 CAMBRIDGE MA 02139
Business Address
Milne Jill C. (Reporting) CIK: 0001644246 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37467 | Film No.: 161883531